Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation
This study is currently recruiting participants.
Study NCT00169247 Information provided by Groupe Oncologie Radiotherapie Tete et Cou
First Received: September 12, 2005 Last Updated: September 23, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Larynx Cancer
Hypopharynx Cancer
Additional conditions recognized in this trial
Hypopharyngeal Neoplasms
Laryngeal Neoplasms
More general conditions related to this trial
Head and Neck Neoplasms
Laryngeal Diseases
Neoplasms
Neoplasms by Site
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Pharyngeal Diseases
Pharyngeal Neoplasms
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
cetuximab
Cisplatin
Radiotherapy 70 Gy, 35 fractions
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Groupe Oncologie Radiotherapie Tete et Cou
Groupe d'Etude des Tumeurs de la Tête Et du Cou
Back to top of Main Content